Converting fibroblast cells into induced pluripotent stem cells
Official title: Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells
Run by Hadassah Medical Organization · NCT00801372 · Data updated 2026-11-12
This study is testing whether skin cells can be turned into special stem cells that might help with future medical treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1 (estimated) |
| Sponsor | Hadassah Medical Organization Academic / other |
| Locations | 1 site (Jerusalem, Israel) |
| Status | Recruiting |
| Started | November 2008 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT00801372 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy individuals aged 18 and older.
✕Probably not a fit
Patients who are not healthy or younger than 18 years old will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to develop human induced pluripotent stem (iPS) cells from existing fibroblast lines originally donated for clinical applications. The study will explore the reprogramming process of somatic cells into an embryonic state and investigate the properties and potential of these iPS cells. Various experimental systems will be employed to characterize the iPS cells, focusing on their biology, developmental potential, and ability to differentiate into functional cell types. The research will be conducted under Good Manufacturing Practice (GMP) conditions to ensure suitability for future clinical applications.
Why it matters
Potential benefit: If successful, this research could provide a limitless source of cells for transplantation and regenerative medicine.
How similar studies have gone: Other studies have shown promise in the field of induced pluripotent stem cells, indicating that this approach has potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * healthy, older than 18 Exclusion Criteria: * non healthy, younger than 18
Where it's running
-
Hadassah Ein Kerem
Jerusalem, Israel, Israel Recruiting
Study contacts
- Principal investigator: Benjamin E Reubinoff, MD PhD — Chairman of Department of Obstetrics & Gynecology/IVF, Hadassah Ein Kerem
- Study coordinator: Benjamin E Reubinoff, MD PhD
- Email: benjaminr@ekmd.huji.ac.il
- Phone: 011-972-2-6774569
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rigid hymenal ring: a surgical option for insertional dyspareunia
This study tests whether surgically removing a rigid hymenal ring helps reduce pain during penetration for women with insertional dyspareunia.
-
Combination of Deferiprone and N-Acetylcysteine for Negative Symptoms in Schizophrenia
This study tests whether adding deferiprone and NAC to the usual antipsychotic treatment can help people with schizophrenia or schizoaffective disorder who have prominent negative symptoms.
-
Using a simple breathing test to detect and monitor BOS after stem cell transplant
This study tests whether the Forced Oscillation Technique (FOT) can help diagnose and track bronchiolitis obliterans syndrome in people who have had an allogeneic hematopoietic stem cell transplant.
-
CRAFT-G: a remote group program to help brain function after breast cancer
A remotely delivered group program called CRAFT-G tests whether group cognitive retraining and functional strategies can help breast cancer survivors with cognitive symptoms feel and function better.
-
Virtual reality relaxation to reduce pain during elective egg retrieval
This tests whether about 20 minutes of relaxing VR nature scenes before elective egg retrieval can lower pain for women having egg freezing.
-
Skin glue plus buried stitch versus buried stitch alone for cesarean wound closure
This trial tests whether adding skin glue to the buried stitch improves wound healing, scar appearance, and patient satisfaction after elective cesarean delivery in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.